title: Fibrates, glitazones, and peroxisome proliferator-activated receptors.
abstract: Several decades ago, fibrates were approved for the treatment of dyslipidemia, whereas thiazolidinediones were screened in animal models to improve glucose homeostasis and were subsequently developed for the treatment of type 2 diabetes mellitus. Relatively recently, these drugs were found to act via peroxisome proliferator-activated receptors, nuclear receptors that control lipid metabolism and glucose homeostasis. In this historical perspective, we discuss the history of discovery of the peroxisome proliferator-activated receptors, from the clinical development of their agonists to the subsequent discovery of these receptors and their mechanisms of action, to finally evoke possibilities of targeted pharmacology for future development of selective peroxisome proliferator-activated receptor modulators.
authors.affiliation: University Lille Nord de France, Lille, France.
authors.forename: Fanny
authors.initials: F
authors.lastname: Lalloyer
authors.forename: Bart
authors.initials: B
authors.lastname: Staels
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D002995:Clofibric Acid / Q000266:history* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000266:history*; D055808:Drug Discovery / Q000266:history; D050171:Dyslipidemias / Q000188:drug therapy / Q000266:history*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007004:Hypoglycemic Agents / Q000266:history* / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000266:history* / Q000627:therapeutic use; D050356:Lipid Metabolism / Q000187:drug effects; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists / Q000266:history*; D045162:Thiazolidinediones / Q000266:history* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D047492:Peroxisome Proliferator-Activated Receptors; D045162:Thiazolidinediones; D002995:Clofibric Acid
references.citation: Diabetes. 1994 Oct;43(10):1203-10
references.pmid: 7926289
references.citation: Circ Res. 2004 May 14;94(9):1168-78
references.pmid: 15142970
references.citation: Fortschr Med. 1978 Oct 12;96(38):1939-41
references.pmid: 700582
references.citation: Lancet. 2009 Jul 11;374(9684):126-35
references.pmid: 19515415
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3444-9
references.pmid: 16492734
references.citation: Curr Opin Pharmacol. 2006 Dec;6(6):606-14
references.pmid: 16973418
references.citation: Chem Pharm Bull (Tokyo). 1982 Oct;30(10):3563-73
references.pmid: 7160011
references.citation: Bioorg Med Chem Lett. 2003 May 5;13(9):1517-21
references.pmid: 12699745
references.citation: Lancet. 1962 Jun 23;1(7243):1323-6
references.pmid: 14037855
references.citation: Bull Mem Soc Med Hop Paris. 1953 Nov 27-Dec 4;69(30-31):1030-48
references.pmid: 13141149
references.citation: Arch Int Pharmacodyn Ther. 1969 Oct;181(2):386-93
references.pmid: 4397540
references.citation: EMBO J. 1992 Feb;11(2):433-9
references.pmid: 1537328
references.citation: J Biol Chem. 1995 Jun 2;270(22):12953-6
references.pmid: 7768881
references.citation: Cell. 1992 Mar 6;68(5):879-87
references.pmid: 1312391
references.citation: Food Chem Toxicol. 1993 Nov;31(11):857-907
references.pmid: 8258416
references.citation: Proc Natl Acad Sci U S A. 1986 Mar;83(6):1747-51
references.pmid: 3456610
references.citation: N Engl J Med. 2006 Dec 7;355(23):2427-43
references.pmid: 17145742
references.citation: Diabetes. 1969 May;18(5):285-91
references.pmid: 4894161
references.citation: Bull Acad Natl Med. 1953 Jul 7-28;137(25-26-27):441-2
references.pmid: 13094180
references.citation: J Med Chem. 1994 Nov 11;37(23):3977-85
references.pmid: 7966158
references.citation: N Engl J Med. 1998 Mar 26;338(13):916-7
references.pmid: 9518284
references.citation: Lancet. 2005 Oct 8;366(9493):1279-89
references.pmid: 16214598
references.citation: Diabetes. 1983 Sep;32(9):804-10
references.pmid: 6354788
references.citation: Cancer Res. 2004 Jun 1;64(11):3849-54
references.pmid: 15172993
references.citation: Nature. 1992 Aug 27;358(6389):771-4
references.pmid: 1324435
references.citation: Arzneimittelforschung. 1980;30(4):585-9
references.pmid: 7190396
references.citation: Nature. 1980 Jan 24;283(5745):397-8
references.pmid: 6766207
references.citation: Mol Cell Biol. 1995 Jun;15(6):3012-22
references.pmid: 7539101
references.citation: Lancet. 2005 Nov 26;366(9500):1849-61
references.pmid: 16310551
references.citation: Regul Toxicol Pharmacol. 1998 Feb;27(1 Pt 2):47-60
references.pmid: 9618323
references.citation: Cell. 1994 Dec 30;79(7):1147-56
references.pmid: 8001151
references.citation: Endocrinology. 1990 Apr;126(4):2153-63
references.pmid: 2318160
references.citation: Atherosclerosis. 1983 Jan;46(1):105-16
references.pmid: 6838687
references.citation: Genes Dev. 1994 May 15;8(10):1224-34
references.pmid: 7926726
references.citation: Science. 1975 Nov 21;190(4216):787-9
references.pmid: 1198095
references.citation: J Cell Biol. 1969 Mar;40(3):734-46
references.pmid: 5765763
references.citation: Nature. 1990 Oct 18;347(6294):645-50
references.pmid: 2129546
references.citation: Diabetes. 1988 Nov;37(11):1549-58
references.pmid: 3053303
references.citation: J Biol Chem. 1999 Mar 5;274(10):6718-25
references.pmid: 10037770
references.citation: J Lipid Res. 2005 May;46(5):1009-16
references.pmid: 15716581
references.citation: Chem Pharm Bull (Tokyo). 1982 Oct;30(10):3580-600
references.pmid: 7160012
references.citation: J Atheroscler Res. 1963 Sep-Dec;3:454-66
references.pmid: 14100886
references.citation: Nature. 1965 Nov 27;208(5013):856-8
references.pmid: 5870099
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5306-11
references.pmid: 11309497
references.citation: Nature. 1962 Jun 9;194:948-9
references.pmid: 13921051
references.citation: Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):542-53
references.pmid: 18628776
references.citation: Hepatology. 2008 Aug;48(2):432-41
references.pmid: 18627005
references.citation: J Atheroscler Res. 1963 Sep-Dec;3:427-44
references.pmid: 14100884
references.citation: Bioorg Med Chem Lett. 2007 Feb 15;17(4):1052-5
references.pmid: 17129725
references.citation: Arzneimittelforschung. 1990 Jan;40(1):37-42
references.pmid: 2339998
references.citation: Circulation. 1998 Nov 10;98(19):2088-93
references.pmid: 9808609
references.citation: Arzneimittelforschung. 1980;30(3):454-9
references.pmid: 7387754
references.citation: PLoS Biol. 2004 Oct;2(10):e294
references.pmid: 15328533
references.citation: FASEB J. 2003 Dec;17(15):2299-301
references.pmid: 14525942